Millipore Sigma Vibrant Logo

428150 Lavendustin A - CAS 125697-92-9 - Calbiochem

A cell-permeable, reversible, and substrate competitive inhibitor of EGF receptor tyrosine kinase and p60c-src with little effect on protein kinase A or protein kinase C.

Lavendustin A - CAS 125697-92-9 - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: 5-Amino-[(N-2,5-dihydroxybenzyl)-Nʹ-2-hydroxybenzyl]salicylic Acid, RG14355

Primary Target: EGF receptor tyrosine kinase
View Products on Sigmaaldrich.com
428150
Preis & Verfügbarkeit

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
125697-92-9C₂₁H₁₉NO₆

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
428150-1MG
Verfügbarkeit wird abgerufen...
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      		 Kst.-Ampulle 1 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      —
      Bitte erfragen
      		 —
      Description
      OverviewA cell-permeable, reversible, and substrate competitive inhibitor of EGF receptor tyrosine kinase (IC50 = 11 nM) and p60c-src (IC50 = 500 nM) with little effect on protein kinase A or protein kinase C (IC50 > 200 µM). Also inhibits NMDA-stimulated cGMP production (IC50 = 30 nM). Exhibits anti-proliferative properties. Suppresses the angiogenic action of vascular endothelial growth factor (VEGF) in rats.
      Catalogue Number428150
      Brand Family Calbiochem®
      Synonyms5-Amino-[(N-2,5-dihydroxybenzyl)-Nʹ-2-hydroxybenzyl]salicylic Acid, RG14355
      References
      ReferencesHu, D.E., and Fan, T.-P. 1995. Br. J. Pharmacol. 114, 262.
      Rodriguez, J., et al. 1994. Neuropharmacology 33, 1267.
      Hsu, C.-Y., et al. 1991. J. Biol. Chem. 266, 21105.
      O’Dell, T.J., et al. 1991. Nature 353, 558; Onoda, T., et al. 1989. J. Nat. Prod. 52, 1252.
      Bishop, J.M. 1983. Annu. Rev. Biochem. 52, 307.
      Product Information
      CAS number125697-92-9
      ATP CompetitiveN
      FormOff-white solid
      Hill FormulaC₂₁H₁₉NO₆
      Chemical formulaC₂₁H₁₉NO₆
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetEGF receptor tyrosine kinase
      Primary Target IC<sub>50</sub>11 nM and 500 nM against EGF receptor tyrosine kinase and p60c-src, respectively
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      428150-1MG 04055977210545

      Documentation

      Lavendustin A - CAS 125697-92-9 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Lavendustin A - CAS 125697-92-9 - Calbiochem Analysenzertifikate

      TitelChargennummer
      428150

      Literatur

      Übersicht
      Hu, D.E., and Fan, T.-P. 1995. Br. J. Pharmacol. 114, 262.
      Rodriguez, J., et al. 1994. Neuropharmacology 33, 1267.
      Hsu, C.-Y., et al. 1991. J. Biol. Chem. 266, 21105.
      O’Dell, T.J., et al. 1991. Nature 353, 558; Onoda, T., et al. 1989. J. Nat. Prod. 52, 1252.
      Bishop, J.M. 1983. Annu. Rev. Biochem. 52, 307.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision17-December-2018 JSW
      Synonyms5-Amino-[(N-2,5-dihydroxybenzyl)-Nʹ-2-hydroxybenzyl]salicylic Acid, RG14355
      DescriptionA cell-permeable, reversible, substrate competitive, and potent inhibitor of EGF receptor tyrosine kinase (IC50 = 11 nM) and pp60c-src (IC50 = 500 nM) with little effect on protein kinase A or protein kinase C (IC50 >200 µM). Also inhibits NMDA-stimulated cGMP production (IC50 = 30 nM). Exhibits anti-proliferative properties. Suppresses the angiogenic action of vascular endothelial growth factor in rats.
      FormOff-white solid
      CAS number125697-92-9
      Chemical formulaC₂₁H₁₉NO₆
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO or Ethanol (10 mg/ml). Further dilute with aqueous buffer just prior to use.
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
      Toxicity Standard Handling
      ReferencesHu, D.E., and Fan, T.-P. 1995. Br. J. Pharmacol. 114, 262.
      Rodriguez, J., et al. 1994. Neuropharmacology 33, 1267.
      Hsu, C.-Y., et al. 1991. J. Biol. Chem. 266, 21105.
      O’Dell, T.J., et al. 1991. Nature 353, 558; Onoda, T., et al. 1989. J. Nat. Prod. 52, 1252.
      Bishop, J.M. 1983. Annu. Rev. Biochem. 52, 307.